AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionEquitable Trust Co
Latest Disclosed Ownership35,133 shares
Latest Disclosed Value $ 7,641,076
Equitable Trust Co reports 3.31% decrease in ownership of 4AB / AbbVie Inc.

On April 30, 2026 - Equitable Trust Co filed a 13F-HR form disclosing ownership of 35,133 shares of AbbVie Inc. (BG:4AB) valued at $7,641,076 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 36,335 shares of AbbVie Inc.. This represents a change in shares of -3.31% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F AbbVie Com 00287Y109 35,133 -1,202 -3.31 7,641 -7.96 0.2079
2026-02-02 2025-12-31 13F AbbVie Com 00287Y109 36,335 363 1.01 8,302 -0.31 0.3707
2025-11-10 2025-09-30 13F AbbVie Com 00287Y109 35,972 33 0.09 8,329 24.86 0.3829
2025-07-23 2025-06-30 13F AbbVie Com 00287Y109 35,939 193 0.54 6,671 -10.94 0.3324
2025-04-25 2025-03-31 13F AbbVie Com 00287Y109 35,746 923 2.65 7,490 21.02 0.4149
2025-01-28 2024-12-31 13F AbbVie Com 00287Y109 34,823 597 1.74 6,188 -8.43 0.3454
2024-10-29 2024-09-30 13F AbbVie Com 00287Y109 34,226 2,698 8.56 6,759 24.99 0.4337
2024-07-31 2024-06-30 13F AbbVie Com 00287Y109 31,528 960 3.14 5,408 -2.86 0.3720
2024-04-24 2024-03-31 13F AbbVie Com 00287Y109 30,568 1,413 4.85 5,566 23.20 0.3861
2024-01-25 2023-12-31 13F AbbVie Com 00287Y109 29,155 3,681 14.45 4,518 18.99 0.3397
2023-11-06 2023-09-30 13F AbbVie Com 00287Y109 25,474 617 2.48 3,797 13.41 0.3139
2023-08-08 2023-06-30 13F AbbVie Com 00287Y109 24,857 -481 -1.90 3,349 -17.09 0.2561
2023-05-02 2023-03-31 13F AbbVie Com 00287Y109 25,338 -398 -1.55 4,038 -2.91 0.3180
2023-02-17 2022-12-31 13F AbbVie Com 00287Y109 25,736 890 3.58 4,159 24.71 0.3278
2022-10-31 2022-09-30 13F AbbVie Com 00287Y109 24,846 535 2.20 3,335 -10.45 0.2780
2022-07-15 2022-06-30 13F AbbVie Com 00287Y109 24,311 1,348 5.87 3,724 0.03 0.2774
2022-05-06 2022-03-31 13F AbbVie Com 00287Y109 22,963 4,692 25.68 3,723 50.49 0.2392
2022-01-31 2021-12-31 13F AbbVie Com 00287Y109 18,271 -1,272 -6.51 2,474 17.36 0.1528
2021-10-26 2021-09-30 13F AbbVie Com 00287Y109 19,543 -2,131 -9.83 2,108 -13.64 0.1346
2021-08-03 2021-06-30 13F AbbVie Com 00287Y109 21,674 -4,510 -17.22 2,441 -13.87 0.1565
2021-05-14 2021-03-31 13F AbbVie Com 00287Y109 26,184 -2,770 -9.57 2,834 -8.67 0.2111
2021-02-12 2020-12-31 13F AbbVie Com 00287Y109 28,954 503 1.77 3,103 24.52 0.2304
2020-11-13 2020-09-30 13F AbbVie Com 00287Y109 28,451 0 0.00 2,492 -10.78 0.2122
2020-08-18 2020-06-30 13F AbbVie Com 00287Y109 28,451 149 0.53 2,793 29.49 0.2569
2020-05-21 2020-03-31 13F AbbVie Com 00287Y109 28,302 -2,579 -8.35 2,157 -21.10 0.2371
2020-02-18 2019-12-31 13F AbbVie Com 00287Y109 30,881 -3,898 -11.21 2,734 3.84 0.2671
2019-11-19 2019-09-30 13F AbbVie Com 00287Y109 34,779 14,265 69.54 2,633 76.47 0.2774
2019-08-16 2019-06-30 13F AbbVie Com 00287Y109 20,514 -4,027 -16.41 1,492 -24.57 0.1583
2019-05-15 2019-03-31 13F AbbVie Com 00287Y109 24,541 230 0.95 1,978 -11.74 0.2284
2019-02-22 2018-12-31 13F AbbVie Com 00287Y109 24,311 -194 -0.79 2,241 -3.32 0.2965
2018-11-15 2018-09-30 13F AbbVie Com 00287Y109 24,505 8,613 54.20 2,318 57.47 0.2701
2018-08-14 2018-06-30 13F AbbVie Com 00287Y109 15,892 15,892 1,472 0.1864
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.